Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mailland

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Arzneimittel-Forschung|December 1, 1993
Evaluation of the mutagenicity of a-dihydroergocryptine in vitro and in vivoK Adams, J A Allen, P C Brooker, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2014
Ability of hydroxypropyl chitosan nail lacquer to protect against dermatophyte nail infectionM A Ghannoum, L Long, N Isham, et al.
Arzneimittel-Forschung|December 1, 1994
Genotoxicity testing of pidotimod in vitro and in vivoK Adams, J A Allen, P C Brooker, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1993
Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal womenC Nappi, G Colace, C Di Carlo, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre studyE Ambrosioni, W Birkenhäger, P W De Leeuw, et al.
Arzneimittel-Forschung|December 1, 1994
Toxicological evaluation of pidotimodG Coppi, M Amico-Roxas, F Bertè, et al.
Headache|March 31, 2001
Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizineG Bussone, R Cerbo, N Martucci, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Arzneimittel-Forschung|December 1, 1993
Evaluation of the mutagenicity of a-dihydroergocryptine in vitro and in vivoK Adams, J A Allen, P C Brooker, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2014
Ability of hydroxypropyl chitosan nail lacquer to protect against dermatophyte nail infectionM A Ghannoum, L Long, N Isham, et al.
Arzneimittel-Forschung|December 1, 1994
Genotoxicity testing of pidotimod in vitro and in vivoK Adams, J A Allen, P C Brooker, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1993
Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal womenC Nappi, G Colace, C Di Carlo, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre studyE Ambrosioni, W Birkenhäger, P W De Leeuw, et al.
Arzneimittel-Forschung|December 1, 1994
Toxicological evaluation of pidotimodG Coppi, M Amico-Roxas, F Bertè, et al.
Headache|March 31, 2001
Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizineG Bussone, R Cerbo, N Martucci, et al.
Pageof 4